BCL2L13 anticorps (Middle Region)
-
- Antigène Voir toutes BCL2L13 Anticorps
- BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))
-
Épitope
- Middle Region
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BCL2L13 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogène
- BCL2 L13 antibody was raised in rabbit using the middle region of BCL2 13 as the immunogen
- Top Product
- Discover our top product BCL2L13 Anticorps primaire
-
-
- Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
BCL2L13 Blocking Peptide, catalog no. 33R-9493, is also available for use as a blocking control in assays to test for specificity of this BCL2L13 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Antigène
- BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))
- Autre désignation
- BCL2L13 (BCL2L13 Produits)
- Synonymes
- anticorps si:ch211-238n5.7, anticorps Mil1, anticorps BCL-RAMBO, anticorps Bcl2-L-13, anticorps MIL1, anticorps E430016C20Rik, anticorps Mil-1, anticorps BCL2 like 13, anticorps BCL2-like 13 (apoptosis facilitator), anticorps BCL2L13, anticorps bcl2l13, anticorps Bcl2l13
- Sujet
- BCL2L13 May promote the activation of caspase-3 and apoptosis. Synonyms: Polyclonal BCL2L13 antibody, Anti-BCL2L13 antibody, BCL2-like 13, apoptosis facilitator antibody, BCL-RAMBO antibody, MIL1 antibody.
- Pathways
- Positive Regulation of Endopeptidase Activity
-